BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 285455)

  • 21. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
    Campr V
    Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathology of bone marrow in human chronic leukemias.
    Georgii A
    Haematol Blood Transfus; 1979; 23():59-70. PubMed ID: 296116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders.
    Douer D; Fabian I; Cline MJ
    Br J Haematol; 1983 Jul; 54(3):373-81. PubMed ID: 6574788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    J Clin Pathol; 1986 Mar; 39(3):237-52. PubMed ID: 3457024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
    Greenberg P; Mara B; Bax I; Brossel R; Schrier S
    Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The histopathology of chronic myeloproliferative diseases.
    Georgii A; Buesche G; Kreft A
    Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies.
    Ohler L; Geissler K; Hinterberger W
    Wien Klin Wochenschr; 2003 Aug; 115(13-14):537-46. PubMed ID: 13677271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of aplastic anemia-PNH syndrome occurred in a 13-year-old girl (author's transl)].
    Yokoya S; Suda T; Yanagisawa M; Mizoguchi H; Miura Y
    Rinsho Ketsueki; 1979 Aug; 20(8):952-7. PubMed ID: 502010
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].
    Jahn M; Zönnchen B; Köpcke W; Hehlmann R
    Klin Wochenschr; 1988 Mar; 66(5):190-8. PubMed ID: 3163063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cells and the microenvironment in aplastic anaemia.
    Gordon MY
    Br J Haematol; 1994 Jan; 86(1):190-2. PubMed ID: 8011528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow biopsy in clinical medicine: an overview.
    Frisch B; Bartl R; Burkhardt R
    Haematologia (Budap); 1982; 15(3):245-85. PubMed ID: 6764442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
    Rizk S; Ibrahim IY; Mansour IM; Kandil D
    J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria.
    Tooze JA; Marsh JC; Gordon-Smith EC
    Leuk Lymphoma; 1999 Apr; 33(3-4):231-41. PubMed ID: 10221503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
    Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
    Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.